Brief: Achilles Therapeutics Posts Q2 Loss Per Share $0.45
10/08/2021 12:52
Aug 10 (Reuters) - Achilles Therapeutics Plc 698y.F :
* ACHILLES THERAPEUTICS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* Q2 LOSS PER SHARE $0.45
Source text for Eikon: ID:nGNXrXJjf
Further company coverage: 698y.F
((reuters.briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement